Citation Impact
Citing Papers
Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: Prognostic Factors and Impact on Survival
2006
Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms
2015
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
2004 StandoutScience
Phase II evaluation of fluorouracil and recombinant α-2a-interferon in previously untreated patients with pancreatic adenocarcinoma
1992
A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer
2002
Postoperative Nomogram for 12-Year Sarcoma-Specific Death
2002
An investigational new drug treatment program for patients with gemcitabine
1999
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study – The UK ABC-01 Study
2009
Chemotherapy enhances TNF-related apoptosis-inducing ligand DISC assembly in HT29 human colon cancer cells
2003
EGFR Antagonists in Cancer Treatment
2008 Standout
Pancreatic cancer
2004 Standout
Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapy
2002
Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM)
2001
Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer.
1998
Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities.
1996 Standout
The Effect of Dietary Supplementation with n—3 Polyunsaturated Fatty Acids on the Synthesis of Interleukin-1 and Tumor Necrosis Factor by Mononuclear Cells
1989 Standout
Modified Staging System for Extremity Soft Tissue Sarcomas
1999
Doxorubicin and doxorubicinol pharmacokinetics and tissue concentrations following bolus injection and continuous infusion of doxorubicin in the rabbit
1993
Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium.
1988
International Collaboration is Feasible in Trials for Rare Conditions: The EURAMOS Experience
2009
Soft Tissue Sarcomas
2004
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
2004 Standout
A Systematic Overview of Radiation Therapy Effects in Soft Tissue Sarcomas
2003
A Novel Imaging System Permits Real-time in Vivo Tumor Bed Assessment After Resection of Naturally Occurring Sarcomas in Dogs
2012
Pain and depression in patients with newly diagnosed pancreas cancer.
1995
Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy
2005 Standout
Induction by Toxic-Shock-Syndrome Toxin-1 of a Circulating Tumor Necrosis Factor-Like Substance in Rabbits and of Immunoreactive Tumor Necrosis Factor and Interleukin-1 from Human Mononuclear Cells
1988
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.
1998
Tumor necrosis factor α stimulates leukotriene production in vivo
1988 StandoutNobel
Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial
2002 Standout
Paclitaxel (Taxol)
1995 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial.
1997
Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma
2005
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
1997 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Soft-Tissue Sarcomas in Adults
2005 Standout
Fluorouracil vs Gemcitabine Chemotherapy Before and After Fluorouracil-Based Chemoradiation Following Resection of Pancreatic Adenocarcinoma
2008
Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma
2001
Pancreatic Adenocarcinoma
2014 Standout
Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer.
1994
Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function
2004 StandoutNobel
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.
1997
Proinflammatory and Anti-inflammatory Cytokines as Mediators in the Pathogenesis of Septic Shock
1997
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer
1996
Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer
1991 Standout
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
2010 Standout
Carboplatin: current status and future prospects
1988
Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis
1992 Standout
Congestive heart failure in patients treated with doxorubicin
2003 Standout
A phase II study of weekly irinotecan as first-line therapy for patients with metastatic pancreatic cancer
2006
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
2007 Standout
Imaging Primary Mouse Sarcomas After Radiation Therapy Using Cathepsin-Activatable Fluorescent Imaging Agents
2013 StandoutNobel
Epirubicin
1993
Adjuvant therapy in pancreatic cancer: historical and current perspectives
2003
Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.
1998 Standout
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
1997 Standout
Neoadjuvant chemotherapy for osteosarcoma of the extremity
2001
Delaying surgery with chemotherapy for osteosarcoma of the extremities
2004
Pancreatic Cancer
2010 Standout
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
1999 Standout
High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas
2000
Randomized Clinical Trials in Soft Tissue Sarcoma
2002
How TNF was recognized as a key mechanism of disease
2007
Multifactorial Analysis of Long-term Follow-up (More Than 5 Years) of Primary Extremity Sarcoma
1999
Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases
1996 Standout
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
2002 Standout
Brachytherapy for Locally Recurrent Soft-Tissue Sarcoma
2002
SFOP OS94: A randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients
2007
Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.
1988
Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: initial results
2006 StandoutNobel
Preservation of Fertility in Patients with Cancer
2009 Standout
Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.
1989
Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis.
1989 StandoutNobel
Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival
2000
The immunopathogenesis of sepsis
2002 StandoutNature
Common Musculoskeletal Tumors of Childhood and Adolescence
1999
Pancreatic cancer
2011 Standout
Accuracy of Biopsy Techniques for Limb and Limb Girdle Soft Tissue Tumors
2001
A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer
2005
MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia
1993 StandoutNature
Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer.
1989
Irinotecan Plus Gemcitabine Induces Both Radiographic and CA 19-9 Tumor Marker Responses in Patients With Previously Untreated Advanced Pancreatic Cancer
2002
Localized Extremity Soft Tissue Sarcoma: Improved Knowledge With Unchanged Survival Over Time
2003
Gemcitabine Combined With Oxaliplatin in Advanced Pancreatic Adenocarcinoma: Final Results of a GERCOR Multicenter Phase II Study
2002
The Staphylococcal Enterotoxins and Their Relatives
1990 StandoutScience
Prognostic Factors for the Outcome of Chemotherapy in Advanced Soft Tissue Sarcoma: An Analysis of 2,185 Patients Treated With Anthracycline-Containing First-Line Regimens—A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study
1999
A Proportional Hazards Model for the Subdistribution of a Competing Risk
1999 Standout
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma.
1997
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
Prognostic Factors for Survival in Previously Treated Patients With Metastatic Renal Cell Carcinoma
2004
Consensus Report of the National Cancer Institute Clinical Trials Planning Meeting on Pancreas Cancer Treatment
2009
Twenty-Two Years of Phase III Trials for Patients With Advanced Non–Small-Cell Lung Cancer: Sobering Results
2001
On the Use of Cause-Specific Failure and Conditional Failure Probabilities: Examples from Clinical Oncology Data
1993
Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
2004 Standout
Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity.
1988
Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale.
2002
Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma
2002
Proposal for classifying the acute emetogenicity of cancer chemotherapy.
1997 Standout
Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial
2005
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II Trial
2004
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
Cytokine dysregulation and acute graft-versus-host disease
1992
Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Gemcitabine Alone in Advanced Pancreatic Cancer
2006
Clinical Benefit and Quality of Life in Patients With Advanced Pancreatic Cancer Receiving Gemcitabine Plus Capecitabine Versus Gemcitabine Alone: A Randomized Multicenter Phase III Clinical Trial—SAKK 44/00–CECOG/PAN.1.3.001
2008
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
2015 Standout
Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma
1999 Standout
Cardiotoxicity of Epirubicin/Paclitaxel–Containing Regimens: Role of Cardiac Risk Factors
1999
Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies
2007
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Primary Adult Soft Tissue Sarcoma: Time-Dependent Influence of Prognostic Variables
2002
2002 Update of Recommendations for the Use of Chemotherapy and Radiotherapy Protectants: Clinical Practice Guidelines of the American Society of Clinical Oncology
2002
Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovorin: Interim Results of a Phase III Trial
2003
Marimastat as First-Line Therapy for Patients With Unresectable Pancreatic Cancer: A Randomized Trial
2001
Metastatic pancreatic cancer: Is gemcitabine still the best standard treatment? (Review)
2010
Long-Term Event-Free Survival After Intensive Chemotherapy for Ewing’s Family of Tumors in Children and Young Adults
2003
Works of E. S. Casper being referenced
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer
1996
Phase I trial of intramuscularly administered tumor necrosis factor in patients with advanced cancer.
1989
Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma.
1996
Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity: a study of 423 adults.
1992
Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer.
1987
Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol.
1998
Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma.
1991
Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.
1995
Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment
1985
A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer.
1985
Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomas
1995
Phase II trial of elliptinium in advanced renal cell carcinoma and carcinoma of the breast.
1985
Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
1982
Phase II trial of carboplatin in advanced malignant melanoma.
1987